APONVIE Trademark
Trademark Overview
On Tuesday, September 21, 2021, a trademark application was filed for APONVIE with the United States Patent and Trademark Office. The USPTO has given the APONVIE trademark a serial number of 97038308. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Heron Therapeutics, Inc.. The APONVIE trademark is filed in the Pharmaceutical Products category with the following description:
Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
General Information
| Serial Number | 97038308 |
| Word Mark | APONVIE |
| Filing Date | Tuesday, September 21, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 2, 2023 |
| Registration Number | 7044489 |
| Registration Date | Tuesday, May 2, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 26, 2022 |
Trademark Statements
| Goods and Services | Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, March 2, 2023 |
| First Use In Commerce Date | Thursday, March 2, 2023 |
Trademark Owner History
| Party Name | Heron Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
| Party Name | Heron Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
| Party Name | Heron Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Friday, September 24, 2021 | NEW APPLICATION ENTERED |
| Monday, October 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 23, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 26, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, August 11, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Sunday, December 4, 2022 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, January 17, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 8, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Friday, March 24, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, March 8, 2023 | USE AMENDMENT FILED |
| Friday, March 24, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, March 30, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, March 31, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, May 2, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 2, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, August 16, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
